Industry › BioTech

Press Releases

One More IPO of Legend Capital: Medical Device Supply Chain Service Provider GKHT Medical Goes Public Successfully

Jul 14, 2023 16:17 HKT/SGT

Eisai to Present the Latest Alzheimer's Disease Pipeline and Research

Jul 12, 2023 09:05 HKT/SGT

Veteran Healthcare Communicator Lea Sims Appointed to Lead CGFNS Marketing and Communications

Jul 11, 2023 19:23 HKT/SGT

Veteran Healthcare Communicator Lea Sims Appointed to Lead CGFNS Marketing and Communications

Jul 11, 2023 19:00 HKT/SGT

Avantor Inaugurates Expanded Singapore Hub

Jul 11, 2023 13:00 HKT/SGT

Avantor Inaugurates Expanded Singapore Hub

Jul 11, 2023 13:00 HKT/SGT

Q&M Free Dental Clinic launched to provide free essential dental treatments for underprivileged individuals and families

Jul 10, 2023 23:00 HKT/SGT

Eisai: FDA Grants Traditional Approval for LEQEMBI (lecanemab-irmb) for the Treatment of Alzheimer's Disease

Jul 07, 2023 12:21 HKT/SGT

エーザイとバイオジェン・インク、「LEQEMBI(R)」（レカネマブ）がアルツハイマー病治療薬として米国FDAよりフル承認を取得

Jul 07, 2023 09:00 JST

Moderna Announces Global Regulatory Submissions for Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345

Jul 05, 2023 19:00 HKT/SGT

四环医药（0460.HK）旗下惠升生物研发的司美格鲁肽注射液获批开展临床实验

Jul 05, 2023 09:51 HKT/SGT

四環醫藥（0460.HK）旗下惠升生物研發的司美格魯肽注射液獲批開展臨床實驗

Jul 05, 2023 09:50 HKT/SGT

Sihuan Pharmaceutical (0460.HK): Huisheng Biopharmaceutical's Drug Semaglutide Injection Obtained Approval For Clinical Trial

Jul 05, 2023 09:49 HKT/SGT

Cure Brain Cancer Foundation Unveils Fellowship Awardees

Jun 30, 2023 14:00 HKT/SGT

New NEURii Research Collaboration Between Eisai, Gates Ventures, Health Data Research UK, Lifearc and The University of Edinburgh to Develop Digital Solutions for Dementia is Announced

Jun 30, 2023 10:08 HKT/SGT

Soligenix, Inc. CEO is Featured in an Interview with SmallCaps Daily

Jun 29, 2023 20:00 HKT/SGT

NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun

Jun 29, 2023 18:45 HKT/SGT

NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun

Jun 29, 2023 18:45 HKT/SGT

BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development

Jun 29, 2023 17:00 HKT/SGT

BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development

Jun 29, 2023 17:00 HKT/SGT